Scientists have developed a technology that shows how in healthy cells are altered when they become cancerous, offering the prospect of changing the way the is diagnosed and managed. “This study addresses one of today’s most perplexing questions in cancer research – why some cancers have no, or a limited number of, cancer-causing mutations,” says Prof. Toshikazu Ushijima, head of epigenomics at the National Cancer Center Research Institute in Tokyo.

READ FULL ARTICLE Curated publisher From Medical News Today